DUCTAL ADENOCARCINOMA OF PANCREAS

This adverse event was reported 277 times

These drugs are most commonly taken by patients reporting DUCTAL ADENOCARCINOMA OF PANCREAS:

# Drug Count
0 OXALIPLATIN 110
1 FLUOROURACIL 108
2 FLUOROURACIL CREAM, 0.5% 108
3 GEMCITABINE HYDROCHLORIDE 43
4 GEMCITABINE 40
5 SITAGLIPTIN 27
6 PACLITAXEL 25
7 METFORMIN 19
8 METFORMIN ER 500 MG 19
9 METFORMIN ER 750 MG 19
See all common drugs associated with DUCTAL ADENOCARCINOMA OF PANCREAS

DUCTAL ADENOCARCINOMA OF PANCREAS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DORAVIRINE 2 0.0025
1 OXALIPLATIN 110 0.0014
2 FLUOROURACIL CREAM, 0.5% 108 0.0014
3 FLUOROURACIL 108 0.0014
4 GEMCITABINE HYDROCHLORIDE 43 0.0008
5 PIOGLITAZONE AND METFORMIN HYDROCHLORIDE 1 0.0008
6 NATEGLINIDE 1 0.0007
7 IRINOTECAN HYDROCHLORIDE 6 0.0005
8 FLUDROCORTISONE ACETATE 1 0.0004
9 GOLIMUMAB 5 0.0004
See all drugs enriched for association with DUCTAL ADENOCARCINOMA OF PANCREAS